Loading…

Escherichia coli producing SHV-type extended-spectrum  -lactamase is a significant cause of community-acquired infection

Objectives Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (ESBLEC) is an increasingly significant cause of community-acquired infection worldwide. The epidemiological features of CTX-M- and SHV-producing ESBLEC causing community-acquired infections are compared. Methods A multicentr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 2009-04, Vol.63 (4), p.781-784
Main Authors: Rodriguez-Bano, J., Alcala, J., Cisneros, J. M., Grill, F., Oliver, A., Horcajada, J. P., Tortola, T., Mirelis, B., Navarro, G., Cuenca, M., Esteve, M., Pena, C., Llanos, A. C., Canton, R., Pascual, A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1398-75dd23d73c79031d6494e28ca12507bc3e752ce7dd001d2eac9b7ec7c77591263
cites cdi_FETCH-LOGICAL-c1398-75dd23d73c79031d6494e28ca12507bc3e752ce7dd001d2eac9b7ec7c77591263
container_end_page 784
container_issue 4
container_start_page 781
container_title Journal of antimicrobial chemotherapy
container_volume 63
creator Rodriguez-Bano, J.
Alcala, J.
Cisneros, J. M.
Grill, F.
Oliver, A.
Horcajada, J. P.
Tortola, T.
Mirelis, B.
Navarro, G.
Cuenca, M.
Esteve, M.
Pena, C.
Llanos, A. C.
Canton, R.
Pascual, A.
description Objectives Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (ESBLEC) is an increasingly significant cause of community-acquired infection worldwide. The epidemiological features of CTX-M- and SHV-producing ESBLEC causing community-acquired infections are compared. Methods A multicentre cohort study including all community-acquired infections caused by ESBLEC in four geographical areas of Spain was carried out. ESBL characterization was by isoelectric focusing, PCR and sequencing. Demographics, previous healthcare contact, co-morbidity, use of antimicrobials, invasive procedures and type of infection were collected for all patients. Patients with CTX-M- and SHV-producing isolates were compared using logistic regression. Results One hundred and twenty-two cases (95% urinary tract infections) were included. ESBLs were characterized in 112 isolates; 77 isolates (69%) produced CTX-M, 36 (32%) produced SHV and 7 (6%) produced TEM enzymes (8 produced >1 ESBL). Patients with isolates producing CTX-M enzymes only (CTX-M group, n = 70) and SHV enzymes only (SHV group, n = 31) were compared. There were no differences in terms of underlying disease, previous healthcare contact, invasive procedures, antibiotic use or type of infection. Multivariate analysis including geographical area showed that a Charlson Index score of >2 (OR = 4.0; 95% CI = 1.2-12.6) was associated with SHV isolates, while age >60 (4.7; 1.7-12.5) was associated with CTX-M isolates. Conclusions SHV-producing ESBLEC is a significant cause of community-acquired infection in Spain; the clinical epidemiology of such isolates seems very similar to that of CTX-M-producing E . coli . [PUBLICATION ABSTRACT]
doi_str_mv 10.1093/jac/dkp028
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_217665310</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1659906061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1398-75dd23d73c79031d6494e28ca12507bc3e752ce7dd001d2eac9b7ec7c77591263</originalsourceid><addsrcrecordid>eNotkM1KAzEUhYMoWKsbnyC4FGLzM5l0llKqFQQX_myH9OZOm9rJTJMZcN7GZ_HJHKmrA5fDdzkfIdeC3wleqNnOwsx9tlzOT8hEZDlnkhfilEy44pqZTKtzcpHSjnOe63w-IcMywRajh623FJq9p21sXA8-bOjr6oN1Q4sUvzoMDh1LLUIX-5r-fLO9hc7WNiH1iVqa_Cb4yoMNHQXbj-emGoF13QffDczCofcRHfWhGhm-CZfkrLL7hFf_OSXvD8u3xYo9vzw-Le6fGQhVzJnRzknljAJTcCVcnhUZyjlYITU3a1BotAQ0znEunEQLxdogGDBGF0Lmakpujtxx2KHH1JW7po9hfFlKYfJcK8HH0u2xBLFJKWJVttHXNg6l4OWf2XI0Wx7Nql9WoW8g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217665310</pqid></control><display><type>article</type><title>Escherichia coli producing SHV-type extended-spectrum  -lactamase is a significant cause of community-acquired infection</title><source>Oxford Journals Online</source><creator>Rodriguez-Bano, J. ; Alcala, J. ; Cisneros, J. M. ; Grill, F. ; Oliver, A. ; Horcajada, J. P. ; Tortola, T. ; Mirelis, B. ; Navarro, G. ; Cuenca, M. ; Esteve, M. ; Pena, C. ; Llanos, A. C. ; Canton, R. ; Pascual, A.</creator><creatorcontrib>Rodriguez-Bano, J. ; Alcala, J. ; Cisneros, J. M. ; Grill, F. ; Oliver, A. ; Horcajada, J. P. ; Tortola, T. ; Mirelis, B. ; Navarro, G. ; Cuenca, M. ; Esteve, M. ; Pena, C. ; Llanos, A. C. ; Canton, R. ; Pascual, A.</creatorcontrib><description>Objectives Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (ESBLEC) is an increasingly significant cause of community-acquired infection worldwide. The epidemiological features of CTX-M- and SHV-producing ESBLEC causing community-acquired infections are compared. Methods A multicentre cohort study including all community-acquired infections caused by ESBLEC in four geographical areas of Spain was carried out. ESBL characterization was by isoelectric focusing, PCR and sequencing. Demographics, previous healthcare contact, co-morbidity, use of antimicrobials, invasive procedures and type of infection were collected for all patients. Patients with CTX-M- and SHV-producing isolates were compared using logistic regression. Results One hundred and twenty-two cases (95% urinary tract infections) were included. ESBLs were characterized in 112 isolates; 77 isolates (69%) produced CTX-M, 36 (32%) produced SHV and 7 (6%) produced TEM enzymes (8 produced &gt;1 ESBL). Patients with isolates producing CTX-M enzymes only (CTX-M group, n = 70) and SHV enzymes only (SHV group, n = 31) were compared. There were no differences in terms of underlying disease, previous healthcare contact, invasive procedures, antibiotic use or type of infection. Multivariate analysis including geographical area showed that a Charlson Index score of &gt;2 (OR = 4.0; 95% CI = 1.2-12.6) was associated with SHV isolates, while age &gt;60 (4.7; 1.7-12.5) was associated with CTX-M isolates. Conclusions SHV-producing ESBLEC is a significant cause of community-acquired infection in Spain; the clinical epidemiology of such isolates seems very similar to that of CTX-M-producing E . coli . [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkp028</identifier><language>eng</language><publisher>Oxford: Oxford Publishing Limited (England)</publisher><subject>Drug resistance ; E coli ; Epidemiology ; Infections</subject><ispartof>Journal of antimicrobial chemotherapy, 2009-04, Vol.63 (4), p.781-784</ispartof><rights>The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1398-75dd23d73c79031d6494e28ca12507bc3e752ce7dd001d2eac9b7ec7c77591263</citedby><cites>FETCH-LOGICAL-c1398-75dd23d73c79031d6494e28ca12507bc3e752ce7dd001d2eac9b7ec7c77591263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Rodriguez-Bano, J.</creatorcontrib><creatorcontrib>Alcala, J.</creatorcontrib><creatorcontrib>Cisneros, J. M.</creatorcontrib><creatorcontrib>Grill, F.</creatorcontrib><creatorcontrib>Oliver, A.</creatorcontrib><creatorcontrib>Horcajada, J. P.</creatorcontrib><creatorcontrib>Tortola, T.</creatorcontrib><creatorcontrib>Mirelis, B.</creatorcontrib><creatorcontrib>Navarro, G.</creatorcontrib><creatorcontrib>Cuenca, M.</creatorcontrib><creatorcontrib>Esteve, M.</creatorcontrib><creatorcontrib>Pena, C.</creatorcontrib><creatorcontrib>Llanos, A. C.</creatorcontrib><creatorcontrib>Canton, R.</creatorcontrib><creatorcontrib>Pascual, A.</creatorcontrib><title>Escherichia coli producing SHV-type extended-spectrum  -lactamase is a significant cause of community-acquired infection</title><title>Journal of antimicrobial chemotherapy</title><description>Objectives Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (ESBLEC) is an increasingly significant cause of community-acquired infection worldwide. The epidemiological features of CTX-M- and SHV-producing ESBLEC causing community-acquired infections are compared. Methods A multicentre cohort study including all community-acquired infections caused by ESBLEC in four geographical areas of Spain was carried out. ESBL characterization was by isoelectric focusing, PCR and sequencing. Demographics, previous healthcare contact, co-morbidity, use of antimicrobials, invasive procedures and type of infection were collected for all patients. Patients with CTX-M- and SHV-producing isolates were compared using logistic regression. Results One hundred and twenty-two cases (95% urinary tract infections) were included. ESBLs were characterized in 112 isolates; 77 isolates (69%) produced CTX-M, 36 (32%) produced SHV and 7 (6%) produced TEM enzymes (8 produced &gt;1 ESBL). Patients with isolates producing CTX-M enzymes only (CTX-M group, n = 70) and SHV enzymes only (SHV group, n = 31) were compared. There were no differences in terms of underlying disease, previous healthcare contact, invasive procedures, antibiotic use or type of infection. Multivariate analysis including geographical area showed that a Charlson Index score of &gt;2 (OR = 4.0; 95% CI = 1.2-12.6) was associated with SHV isolates, while age &gt;60 (4.7; 1.7-12.5) was associated with CTX-M isolates. Conclusions SHV-producing ESBLEC is a significant cause of community-acquired infection in Spain; the clinical epidemiology of such isolates seems very similar to that of CTX-M-producing E . coli . [PUBLICATION ABSTRACT]</description><subject>Drug resistance</subject><subject>E coli</subject><subject>Epidemiology</subject><subject>Infections</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNotkM1KAzEUhYMoWKsbnyC4FGLzM5l0llKqFQQX_myH9OZOm9rJTJMZcN7GZ_HJHKmrA5fDdzkfIdeC3wleqNnOwsx9tlzOT8hEZDlnkhfilEy44pqZTKtzcpHSjnOe63w-IcMywRajh623FJq9p21sXA8-bOjr6oN1Q4sUvzoMDh1LLUIX-5r-fLO9hc7WNiH1iVqa_Cb4yoMNHQXbj-emGoF13QffDczCofcRHfWhGhm-CZfkrLL7hFf_OSXvD8u3xYo9vzw-Le6fGQhVzJnRzknljAJTcCVcnhUZyjlYITU3a1BotAQ0znEunEQLxdogGDBGF0Lmakpujtxx2KHH1JW7po9hfFlKYfJcK8HH0u2xBLFJKWJVttHXNg6l4OWf2XI0Wx7Nql9WoW8g</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Rodriguez-Bano, J.</creator><creator>Alcala, J.</creator><creator>Cisneros, J. M.</creator><creator>Grill, F.</creator><creator>Oliver, A.</creator><creator>Horcajada, J. P.</creator><creator>Tortola, T.</creator><creator>Mirelis, B.</creator><creator>Navarro, G.</creator><creator>Cuenca, M.</creator><creator>Esteve, M.</creator><creator>Pena, C.</creator><creator>Llanos, A. C.</creator><creator>Canton, R.</creator><creator>Pascual, A.</creator><general>Oxford Publishing Limited (England)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20090401</creationdate><title>Escherichia coli producing SHV-type extended-spectrum  -lactamase is a significant cause of community-acquired infection</title><author>Rodriguez-Bano, J. ; Alcala, J. ; Cisneros, J. M. ; Grill, F. ; Oliver, A. ; Horcajada, J. P. ; Tortola, T. ; Mirelis, B. ; Navarro, G. ; Cuenca, M. ; Esteve, M. ; Pena, C. ; Llanos, A. C. ; Canton, R. ; Pascual, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1398-75dd23d73c79031d6494e28ca12507bc3e752ce7dd001d2eac9b7ec7c77591263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Drug resistance</topic><topic>E coli</topic><topic>Epidemiology</topic><topic>Infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodriguez-Bano, J.</creatorcontrib><creatorcontrib>Alcala, J.</creatorcontrib><creatorcontrib>Cisneros, J. M.</creatorcontrib><creatorcontrib>Grill, F.</creatorcontrib><creatorcontrib>Oliver, A.</creatorcontrib><creatorcontrib>Horcajada, J. P.</creatorcontrib><creatorcontrib>Tortola, T.</creatorcontrib><creatorcontrib>Mirelis, B.</creatorcontrib><creatorcontrib>Navarro, G.</creatorcontrib><creatorcontrib>Cuenca, M.</creatorcontrib><creatorcontrib>Esteve, M.</creatorcontrib><creatorcontrib>Pena, C.</creatorcontrib><creatorcontrib>Llanos, A. C.</creatorcontrib><creatorcontrib>Canton, R.</creatorcontrib><creatorcontrib>Pascual, A.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodriguez-Bano, J.</au><au>Alcala, J.</au><au>Cisneros, J. M.</au><au>Grill, F.</au><au>Oliver, A.</au><au>Horcajada, J. P.</au><au>Tortola, T.</au><au>Mirelis, B.</au><au>Navarro, G.</au><au>Cuenca, M.</au><au>Esteve, M.</au><au>Pena, C.</au><au>Llanos, A. C.</au><au>Canton, R.</au><au>Pascual, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Escherichia coli producing SHV-type extended-spectrum  -lactamase is a significant cause of community-acquired infection</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><date>2009-04-01</date><risdate>2009</risdate><volume>63</volume><issue>4</issue><spage>781</spage><epage>784</epage><pages>781-784</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>Objectives Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (ESBLEC) is an increasingly significant cause of community-acquired infection worldwide. The epidemiological features of CTX-M- and SHV-producing ESBLEC causing community-acquired infections are compared. Methods A multicentre cohort study including all community-acquired infections caused by ESBLEC in four geographical areas of Spain was carried out. ESBL characterization was by isoelectric focusing, PCR and sequencing. Demographics, previous healthcare contact, co-morbidity, use of antimicrobials, invasive procedures and type of infection were collected for all patients. Patients with CTX-M- and SHV-producing isolates were compared using logistic regression. Results One hundred and twenty-two cases (95% urinary tract infections) were included. ESBLs were characterized in 112 isolates; 77 isolates (69%) produced CTX-M, 36 (32%) produced SHV and 7 (6%) produced TEM enzymes (8 produced &gt;1 ESBL). Patients with isolates producing CTX-M enzymes only (CTX-M group, n = 70) and SHV enzymes only (SHV group, n = 31) were compared. There were no differences in terms of underlying disease, previous healthcare contact, invasive procedures, antibiotic use or type of infection. Multivariate analysis including geographical area showed that a Charlson Index score of &gt;2 (OR = 4.0; 95% CI = 1.2-12.6) was associated with SHV isolates, while age &gt;60 (4.7; 1.7-12.5) was associated with CTX-M isolates. Conclusions SHV-producing ESBLEC is a significant cause of community-acquired infection in Spain; the clinical epidemiology of such isolates seems very similar to that of CTX-M-producing E . coli . [PUBLICATION ABSTRACT]</abstract><cop>Oxford</cop><pub>Oxford Publishing Limited (England)</pub><doi>10.1093/jac/dkp028</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 2009-04, Vol.63 (4), p.781-784
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_journals_217665310
source Oxford Journals Online
subjects Drug resistance
E coli
Epidemiology
Infections
title Escherichia coli producing SHV-type extended-spectrum  -lactamase is a significant cause of community-acquired infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A35%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Escherichia%20coli%20producing%20SHV-type%20extended-spectrum%20%C2%A0-lactamase%20is%20a%20significant%20cause%20of%20community-acquired%20infection&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Rodriguez-Bano,%20J.&rft.date=2009-04-01&rft.volume=63&rft.issue=4&rft.spage=781&rft.epage=784&rft.pages=781-784&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/dkp028&rft_dat=%3Cproquest_cross%3E1659906061%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1398-75dd23d73c79031d6494e28ca12507bc3e752ce7dd001d2eac9b7ec7c77591263%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217665310&rft_id=info:pmid/&rfr_iscdi=true